• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激动剂作用的三态受体模型。

A three-state receptor model of agonist action.

作者信息

Leff P, Scaramellini C, Law C, McKechnie K

机构信息

Astra Charnwood, Loughborough, UK.

出版信息

Trends Pharmacol Sci. 1997 Oct;18(10):355-62. doi: 10.1016/s0165-6147(97)01105-x.

DOI:10.1016/s0165-6147(97)01105-x
PMID:9357320
Abstract

The concept that receptors can exist in multiple conformational states is becoming a physical reality. A fundamental question is how many active states need to be proposed in order to account for pharmacological observations, in particular, the finding that the same receptor type can exhibit a different agonist pharmacology when coupled to different effector pathways. In this article, Paul Leff, Clare Scaramellini, Clare Law and Ken McKechnie propose and develop a three-state receptor model in which two active conformations are assumed to exist. They show that this relatively simple theoretical model provides a basis for predicting variable agonist and inverse agonist behaviour in different systems containing the same receptor, and that it is able to account for emerging data obtained on promiscuously coupled receptors. It is argued that, while these new theoretical considerations challenge the fundamental assumptions and concepts of traditional receptor theory, the general principles of pharmacological receptor classification are largely preserved.

摘要

受体可存在多种构象状态这一概念正成为一种物理现实。一个基本问题是,为了解释药理学观察结果,特别是发现同一受体类型与不同效应器途径偶联时可表现出不同的激动剂药理学特性,需要提出多少种活性状态。在本文中,保罗·莱夫、克莱尔·斯卡拉梅利尼、克莱尔·劳和肯·麦基尔尼提出并发展了一种三态受体模型,其中假定存在两种活性构象。他们表明,这个相对简单的理论模型为预测包含相同受体的不同系统中可变的激动剂和反向激动剂行为提供了基础,并且能够解释在杂乱偶联受体上获得的新数据。有人认为,虽然这些新的理论思考挑战了传统受体理论的基本假设和概念,但药理学受体分类的一般原则在很大程度上得以保留。

相似文献

1
A three-state receptor model of agonist action.激动剂作用的三态受体模型。
Trends Pharmacol Sci. 1997 Oct;18(10):355-62. doi: 10.1016/s0165-6147(97)01105-x.
2
The two-state model of agonist action: challenges to pharmacological receptor theory.
Proc West Pharmacol Soc. 1996;39:67-8.
3
Agonist-receptor efficacy. I: Mechanisms of efficacy and receptor promiscuity.激动剂-受体效能。I:效能机制与受体多配性
Trends Pharmacol Sci. 1995 Jun;16(6):188-92. doi: 10.1016/s0165-6147(00)89020-3.
4
A simplified empirical approach to evaluate the dissociation constant of a full agonist by the irreversible receptor inactivation method.一种通过不可逆受体失活法评估完全激动剂解离常数的简化经验方法。
J Pharmacol Toxicol Methods. 1998 Jul;40(1):57-62. doi: 10.1016/s1056-8719(98)00039-2.
5
A three-state receptor model: predictions of multiple agonist pharmacology for the same receptor type.一种三态受体模型:对同一受体类型多种激动剂药理学的预测。
Ann N Y Acad Sci. 1998 Dec 15;861:97-103. doi: 10.1111/j.1749-6632.1998.tb10179.x.
6
Operational models of pharmacological agonism.药理学激动作用的操作模型。
Proc R Soc Lond B Biol Sci. 1983 Dec 22;220(1219):141-62. doi: 10.1098/rspb.1983.0093.
7
Engineering Aspects of Olfaction嗅觉的工程学方面
8
Potential errors in agonist dissociation constant estimation caused by desensitization.
J Theor Biol. 1986 Jul 21;121(2):221-32. doi: 10.1016/s0022-5193(86)80095-9.
9
Inverse agonism or neutral antagonism at G-protein coupled receptors: a medicinal chemistry challenge worth pursuing?G蛋白偶联受体的反向激动作用或中性拮抗作用:一项值得探索的药物化学挑战?
Eur J Pharmacol. 2006 Dec 28;553(1-3):1-9. doi: 10.1016/j.ejphar.2006.09.032. Epub 2006 Sep 26.
10
The two-state model of receptor activation.受体激活的双态模型。
Trends Pharmacol Sci. 1995 Mar;16(3):89-97. doi: 10.1016/s0165-6147(00)88989-0.

引用本文的文献

1
Structural Determinants of Buprenorphine Partial Agonism at the μ-Opioid Receptor.丁丙诺啡对μ-阿片受体部分激动作用的结构决定因素
J Chem Inf Model. 2025 May 26;65(10):5071-5085. doi: 10.1021/acs.jcim.5c00078. Epub 2025 May 6.
2
A F-qNMR-Guided Mathematical Model for G Protein-Coupled Receptor Signaling.基于 F-qNMR 的 G 蛋白偶联受体信号转导数学模型
Mol Pharmacol. 2023 Dec 15;105(1):54-62. doi: 10.1124/molpharm.123.000754.
3
100 years of modelling ligand-receptor binding and response: A focus on GPCRs.100年的配体-受体结合与反应建模:聚焦于G蛋白偶联受体
Br J Pharmacol. 2020 Apr;177(7):1472-1484. doi: 10.1111/bph.14988. Epub 2020 Feb 28.
4
Interdependence of hypoxia and β-adrenergic receptor signaling in pulmonary arterial hypertension.低氧与β肾上腺素能受体信号在肺动脉高压中的相互依赖关系。
Am J Physiol Lung Cell Mol Physiol. 2019 Sep 1;317(3):L369-L380. doi: 10.1152/ajplung.00015.2019. Epub 2019 Jun 26.
5
DRD2 Genotype-Based Variants Modulates D2 Receptor Distribution in Ventral Striatum.DRD2 基因型变异调节腹侧纹状体中 D2 受体的分布。
Mol Neurobiol. 2019 Sep;56(9):6512-6520. doi: 10.1007/s12035-019-1543-0. Epub 2019 Mar 8.
6
An intact model for quantifying functional selectivity.一种用于量化功能选择性的完整模型。
Sci Rep. 2019 Feb 22;9(1):2557. doi: 10.1038/s41598-019-39000-z.
7
Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity.药理学的解析:反向激动作用和功能选择性。
Int J Neuropsychopharmacol. 2018 Oct 1;21(10):962-977. doi: 10.1093/ijnp/pyy071.
8
An evaluation of the operational model when applied to quantify functional selectivity.评估操作模型在定量功能选择性时的应用。
Br J Pharmacol. 2018 May;175(10):1654-1668. doi: 10.1111/bph.14171. Epub 2018 Mar 30.
9
Modelling and simulation of biased agonism dynamics at a G protein-coupled receptor.G蛋白偶联受体上偏向激动剂动力学的建模与模拟
J Theor Biol. 2018 Apr 7;442:44-65. doi: 10.1016/j.jtbi.2018.01.010. Epub 2018 Jan 12.
10
Characterization of structurally novel G protein biased CB agonists: Implications for drug development.结构新颖的 G 蛋白偏向 CB 激动剂的表征:对药物开发的影响。
Pharmacol Res. 2017 Nov;125(Pt B):161-177. doi: 10.1016/j.phrs.2017.08.008. Epub 2017 Aug 23.